Medical News

Study Examines Potential Benefits of Discordant Couple HIV Therapy

From Henry J. Kaiser Family Foundation

October 19, 2011

A new study published online in the journal AIDS uses mathematical models to predict the potential impact of treating discordant couples with antiretroviral therapy, according to a Columbia University Mailman School of Public Health press release. Researchers from ICAP at the Mailman School and UCLA's Center for Biomedical Modeling made predictions for Ghana, Lesotho, Malawi and Rwanda (10/18). According to the study, the "effectiveness of a discordant couples intervention in reducing incidence will vary among countries due to differences in" population size, HIV prevalence and the percentage of couples who are discordant (El-Sadr et al., 10/11).

Back to other news for October 2011

This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.

Quantifying HIV-1 Exposure to Illuminate Resistance to Infection

Early Treatment Reduces HIV Transmission in Heterosexual Serodiscordant Couples

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.

No comments have been made.

Add Your Comment:

(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

HIV Management Today: Mental Health & HIV, the Uncharted Territory

Danish Study Targets HIV Reservoir, in Latest Search for HIV Cure

CROI 2013: Research on Aging and HIV (Video)

PrEP Failures and Successes: One Study Whose Impact Will Last Well Beyond CROI 2013

10 Top Studies Whose Impact Will Last Well Beyond CROI 2013

More >>

TheBodyPRO.com is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. TheBodyPRO.com and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of TheBodyPRO.com's homepage, topic pages, page designs and HTML code. General Disclaimer: TheBodyPRO.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBodyPRO.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.